Sana Biotechnology

(NASDAQ) SANA

Current Price$3.35

Market Cap$869.99M

Since IPO (2021)-91%

5 Year-87%

1 Year+84%

1 Month+18%

Sana Biotechnology Financials at a Glance

Market Cap

$869.99M

Revenue (TTM)

$0.00

Net Income (TTM)

$244.17M

EPS (TTM)

$-0.98

P/E Ratio

-3.34

Dividend

$0.00

Beta (Volatility)

2.12 (High)

Dividend

$0.00

Beta (Volatility)

2.12 (High)

Price

$3.35

Volume

59,092

Open

$3.27

Price

$3.35

Volume

59,092

Open

$3.27

Previous Close

$3.26

Daily Range

$3.25 - $3.38

52-Week Range

$1.60 - $6.55

Dividend

$0.00

Beta (Volatility)

2.12 (High)

Price

$3.35

Volume

59,092

Open

$3.27

Previous Close

$3.26

Daily Range

$3.25 - $3.38

52-Week Range

$1.60 - $6.55

SANA News

smart-investor-studying-stock-charts-getty

SANA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sana Biotechnology

Industry

Biotechnology

Sector

Health Care

Employees

142

CEO

Steven D. Harr, MD

Website

www.sana.com

Headquarters

Seattle, WA 98102, US

SANA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-119%

Return on Capital

-74%

Return on Assets

-59%

Earnings Yield

-29.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$869.99M

Shares Outstanding

266.87M

Volume

59.09K

Avg. Volume

2.89M

Financials (TTM)

Gross Profit

$12.75M

Operating Income

$190.96M

EBITDA

$178.21M

Operating Cash Flow

$143.83M

Capital Expenditure

$938.00K

Free Cash Flow

$144.77M

Cash & ST Invst.

$138.38M

Total Debt

$78.86M

Sana Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$869.99M

N/A

Market Cap/Employee

$4.48M

N/A

Employees

194

N/A

Net Income

$58.83M

-19.9%

EBITDA

$58.15M

-28.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$59.52M

+2.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$63.92M

-21.7%

Short Term Debt

$14.94M

+19.2%

Return on Assets

-58.57%

N/A

Return on Invested Capital

-74.02%

N/A

Free Cash Flow

$33.51M

+29.6%

Operating Cash Flow

$32.64M

+30.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XNCRXencor, Inc.

XNCRXencor, Inc.$12.01-8.32%

PHATPhathom Pharmaceuticals, Inc.

PHATPhathom Pharmaceuticals, Inc.$11.45-1.21%

NRIXNurix Therapeutics, Inc.

NRIXNurix Therapeutics, Inc.$17.23+4.52%

OCSOculis Holding AG

OCSOculis Holding AG$26.76-1.34%

NKTRNektar Therapeutics

NKTRNektar Therapeutics$83.38-3.87%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$21.08+0.38%

INBXInhibrx Biosciences, Inc.

INBXInhibrx Biosciences, Inc.$130.28-0.89%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$83.67-0.02%

NOKNokia

NOKNokia$11.11+0.04%

POETPoet Technologies

POETPoet Technologies$7.86-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.20-0.01%

ERASErasca

ERASErasca$9.82-0.49%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.97+0.03%

PFEPfizer

PFEPfizer$26.43-0.01%

Questions About SANA

What is the current price of Sana Biotechnology?

Sana Biotechnology is trading at $3.35 per share.

What is the 52-week range for Sana Biotechnology?

Over the past 52 weeks, Sana Biotechnology has traded between $1.60 and $6.55.

How much debt does Sana Biotechnology have?

As of the most recent reporting period, Sana Biotechnology reported total debt of $78.86M.

How much cash does Sana Biotechnology have on hand?

Sana Biotechnology reported $76.06M in cash and cash equivalents in its most recent financial results.

What is Sana Biotechnology’s dividend yield?

Sana Biotechnology does not currently have a dividend yield.

Sana Biotechnology

Sana Biotechnology Financials at a Glance

SANA News

2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher?

Why Shares of Sana Biotechnology Jumped This Week

2 Biotech IPO Stocks You'll Want to Have on Your Radar

SANA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sana Biotechnology

SANA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sana Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SANA

What is the current price of Sana Biotechnology?

What is the 52-week range for Sana Biotechnology?

How much debt does Sana Biotechnology have?

How much cash does Sana Biotechnology have on hand?

What is Sana Biotechnology’s dividend yield?

Premium Investing Services